CNXC Stock Analysis: Concentrix | NASDAQ
Information Technology Services | NASDAQ, USA | Market Cap: 1.394m USD | 12M Return: -63.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 45.1M
EPS Trend: -74.3%
Qual. Beats: 0
Rev. Trend: 87.1%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Concentrix Corporation (NASDAQ: CNXC) is a global provider of integrated customer experience (CX) solutions, offering services that span CX process optimization, technology and design engineering, front- and back-office automation, analytics, business transformation, and increasingly, AI-driven capabilities including generative AI and agentic AI assistants. The company serves clients across multiple verticals, including technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance (BFSI), and healthcare, with end-to-end support covering customer lifecycle management, digital operations, data analytics, self-service automation, and voice-of-customer feedback solutions. Founded in 2004 and headquartered in Newark, California, Concentrix went public in late 2020.
The company operates within the Data Processing & Outsourced Services sub-industry (GICS Industrials sector), competing in the business process outsourcing (BPO) and customer experience management space against other global CX and digital services providers. Its business model is built on long-term client contracts that combine human-led support with proprietary and third-party AI technologies to automate interactions, reduce handling costs, and improve customer outcomes across both customer-facing and back-office functions.
- GenAI automation accelerates shift away from human agents
- Webhelp merger expands European footprint and service portfolio
- Top client concentration in tech and consumer electronics creates revenue risk
| Net Income: -1.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.97 > 1.0 |
| NWC/Revenue: 4.61% < 20% (prev 12.44%; Δ -7.83% < -1%) |
| CFO/TA 0.07 > 3% & CFO 743.7m > Net Income -1.31b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.1m) vs 12m ago -3.67% < -2% |
| Gross Margin: 32.41% > 18% (prev 35.73%; Δ -3.32% > 0.5%) |
| Asset Turnover: 87.29% > 50% (prev 77.65%; Δ 9.65% > 0%) |
| Interest Coverage Ratio: -3.33 > 6 (EBIT TTM -951.2m / Interest Expense TTM 285.3m) |
| A: 0.04 (Total Current Assets 3.04b - Total Current Liabilities 2.58b) / Total Assets 10.5b |
| B: -0.01 (Retained Earnings -146.5m / Total Assets 10.5b) |
| C: -0.08 (EBIT TTM -951.2m / Avg Total Assets 11.5b) |
| D: 0.35 (Book Value of Equity 2.70b / Total Liabilities 7.81b) |
| Altman-Z'' = 0.05 = B |
| DSRI: 0.93 (Receivables 1.99b/2.06b, Revenue 10.00b/9.63b) |
| GMI: 1.10 (GM 35.73% / 32.41%) |
| AQI: 0.94 (AQ_t 0.64 / AQ_t-1 0.69) |
| SGI: 1.04 (Revenue 10.00b / 9.63b) |
| TATA: -0.20 (NI -1.31b - CFO 743.7m) / TA 10.5b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 20.97 with a total of 2,468,452 shares traded. Over the past week, the price has changed by -14.09%, over one month by -23.16%, over three months by -25.42% and over the past year by -63.75%.
Current recommended Stop Loss: 18.30 (which is 12.7% or 1.3 ATR below the current price).
Concentrix has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNXC.
- StrongBuy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 35.3 | 68.1% |
P/E Forward = 2.1436
P/S = 0.1394
P/B = 0.5329
P/EG = 0.3062
Revenue TTM = 10.00b USD
EBIT TTM = -951.2m USD
EBITDA TTM = -619.5m USD
Long Term Debt = 3.93b USD (from longTermDebt, last quarter)
Short Term Debt = 650.0m USD (from shortTermDebt, last quarter)
Debt = 4.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.33b USD (calculated: Debt 4.58b - CCE 255.6m)
Enterprise Value = 5.72b USD (1.39b + Debt 4.58b - CCE 255.6m)
Interest Coverage Ratio = -3.33 (Ebit TTM -951.2m / Interest Expense TTM 285.3m)
EV/FCF = 11.15x (Enterprise Value 5.72b / FCF TTM 513.5m)
FCF Yield = 8.97% (FCF TTM 513.5m / Enterprise Value 5.72b)
FCF Margin = 5.14% (FCF TTM 513.5m / Revenue TTM 10.00b)
Net Margin = -13.15% (Net Income TTM -1.31b / Revenue TTM 10.00b)
Gross Margin = 32.41% ((Revenue TTM 10.00b - Cost of Revenue TTM 6.76b) / Revenue TTM)
Gross Margin QoQ = 33.44% (prev 33.98%)
Tobins Q-Ratio = 0.54 (Enterprise Value 5.72b / Total Assets 10.5b)
Interest Expense / Debt = 6.22% (Interest Expense 285.3m / Debt 4.58b)
Taxrate = 20.44% (14.2m / 69.5m)
NOPAT = -756.8m (EBIT -951.2m * (1 - 20.44%)) [loss with tax shield]
Current Ratio = 1.18 (Total Current Assets 3.04b / Total Current Liabilities 2.58b)
Debt / Equity = 1.70 (Debt 4.58b / totalStockholderEquity, last quarter 2.70b)
Debt / EBITDA = -6.99 (negative EBITDA) (Net Debt 4.33b / EBITDA -619.5m)
Debt / FCF = 8.43 (Net Debt 4.33b / FCF TTM 513.5m)
Total Stockholder Equity = 3.14b (last 4 quarters mean from totalStockholderEquity)
RoA = -11.48% (Net Income -1.31b / Total Assets 10.5b)
RoE = -41.80% (Net Income TTM -1.31b / Total Stockholder Equity 3.14b)
RoCE = -13.44% (EBIT -951.2m / Capital Employed (Equity 3.14b + L.T.Debt 3.93b))
RoIC = -9.09% (negative operating profit) (NOPAT -756.8m / Invested Capital 8.33b)
WACC = 6.22% (E(1.39b)/V(5.98b) * Re(10.39%) + D(4.58b)/V(5.98b) * Rd(6.22%) * (1-Tc(0.20)))
Discount Rate = 10.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -3.25%
[DCF] Terminal Value 76.19% ; FCFF base≈502.1m ; Y1≈528.8m ; Y5≈616.3m
[DCF] Fair Price = 84.60 (EV 9.49b - Net Debt 4.33b = Equity 5.16b / Shares 61.0m; r=8.35% [WACC [floored]]; 5y FCF grow 5.90% → 2.50% )
EPS Correlation: -74.32 | EPS CAGR: -6.69% | SUE: 0.06 | # QB: 0
Revenue Correlation: 87.11 | Revenue CAGR: 14.87% | SUE: -0.88 | # QB: -1
EPS current Quarter (2026-08-31): EPS=2.81 | Chg30d=-8.19% | Revisions=+17% | Analysts=4
EPS current Year (2026-11-30): EPS=11.20 | Chg30d=-4.36% | Revisions=-50% | GrowthEPS=-0.2% | GrowthRev=+1.4%
EPS next Year (2027-11-30): EPS=11.89 | Chg30d=-7.38% | Revisions=-40% | GrowthEPS=+6.2% | GrowthRev=+1.3%
[Analyst] Revisions Ratio: -36% (up=2, down=6)